Modulatory therapy

To your attention “Guidelines for the initiation and termination of cystic fibrosis therapy using modulators of the cystic fibrosis transmembrane conductance regulator – CFTR”, which was presented by doctors from the Center for Orphan Diseases and Gene Therapy of the National Research and Development Center “Okhmatdyt” of the Ministry of Health of Ukraine.

Important information in Ukrainian for everyone who starts modulatory therapy, as well as clear recommendations on monitoring, examinations and tests of patients during the first year of treatment, adverse reactions and criteria for discontinuation of treatment.

File link